{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T14:36:33Z","timestamp":1792938993146,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":1543,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1074\/mcp.m115.056036","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T22:08:48Z","timestamp":1462313328000},"page":"2366-2378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids"],"prefix":"10.1016","volume":"15","author":[{"given":"Rustam H.","family":"Ziganshin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga M.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakov A.","family":"Lomakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Alexey A.","family":"Belogurov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey I.","family":"Kovalchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor V.","family":"Azarkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgij P.","family":"Arapidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay A.","family":"Anikanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria O.","family":"Shender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Piradov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia A.","family":"Suponeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Vorobyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Gabibov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim T.","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim M.","family":"Govorun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M115.056036_bib1","series-title":"Neuroimmunology for the clinicians","first-page":"205","article-title":"Guillain-Barr\u00e9 Syndrome","author":"Rostami","year":"1997"},{"key":"10.1074\/mcp.M115.056036_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00194098","article-title":"Guillain-Barre syndrome: clinical and immunological aspects","volume":"17","author":"Rostami","year":"1995","journal-title":"Springer Sem. Immunopathol"},{"key":"10.1074\/mcp.M115.056036_bib3","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1074\/mcp.M115.056036_bib4","first-page":"472","article-title":"Note sur la paralysie ascendante aigue","volume":"6","author":"Landry","year":"1859","journal-title":"Gaz. Hebd. Med. Chir"},{"key":"10.1074\/mcp.M115.056036_bib5","first-page":"1462","article-title":"Sur un syndrome de radiculo -nevrite avec hyperaalbuminose du liquide cephalo-rachidien sans reaction cellulaire. Rematques sur les caracteres cliniques et graphique des reflexes tendineux","volume":"40","author":"Guillain","year":"1916","journal-title":"Bull. et M\u00e9m. de la Soc. M\u00e9d. des H\u00f4p. de Paris"},{"key":"10.1074\/mcp.M115.056036_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1084\/jem.102.2.213","article-title":"Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants","volume":"102","author":"Waksman","year":"1955","journal-title":"J. Exp. Med"},{"key":"10.1074\/mcp.M115.056036_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis","volume":"48","author":"Asbury","year":"1969","journal-title":"Medicine"},{"key":"10.1074\/mcp.M115.056036_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02786446","article-title":"Pathogenesis of neuroimmunologic diseases. Experimental models","volume":"17","author":"Constantinescu","year":"1998","journal-title":"Immunol. Res"},{"key":"10.1074\/mcp.M115.056036_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-5728(00)00270-8","article-title":"Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis","volume":"108","author":"Fujioka","year":"2000","journal-title":"J. Neuroimmunol"},{"key":"10.1074\/mcp.M115.056036_bib10","doi-asserted-by":"crossref","first-page":"589048","DOI":"10.1155\/2013\/589048","article-title":"Different mechanisms of inflammation induced in virus and autoimmune-mediated models of multiple sclerosis in C57BL6 mice","volume":"2013","author":"Kishore","year":"2013","journal-title":"BioMed Res. Int"},{"key":"10.1074\/mcp.M115.056036_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1074\/mcp.M115.056036_bib12","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1007\/s10072-006-0548-4","article-title":"Guillain-Barre syndrome","volume":"27","author":"Cosi","year":"2006","journal-title":"Neurol. Sci"},{"key":"10.1074\/mcp.M115.056036_bib13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1074\/mcp.M115.056036_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3329\/jhpn.v28i6.6602","article-title":"Quantifying the association between Campylobacter infection and Guillain-Barre syndrome: a systematic review","volume":"28","author":"Poropatich","year":"2010","journal-title":"J. Health, Population, Nutrition"},{"key":"10.1074\/mcp.M115.056036_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/cir074","article-title":"Guillain-Barre syndrome following primary cytomegalovirus infection: a prospective cohort study","volume":"52","author":"Orlikowski","year":"2011","journal-title":"Clin. Infectious Dis"},{"key":"10.1074\/mcp.M115.056036_bib16","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"10.1074\/mcp.M115.056036_bib17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mus.20762","article-title":"Ganglioside mimicry and peripheral nerve disease","volume":"35","author":"Yuki","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1074\/mcp.M115.056036_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1074\/mcp.M115.056036_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.410340206","article-title":"Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barre syndrome and controls: correlation and prognosis","volume":"34","author":"Vriesendorp","year":"1993","journal-title":"Anna. Neurol"},{"key":"10.1074\/mcp.M115.056036_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1085-9489.2005.0010209.x","article-title":"Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia","volume":"10","author":"Kamakura","year":"2005","journal-title":"J. Peripheral Nervous Syst"},{"key":"10.1074\/mcp.M115.056036_bib21","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1096\/fj.11-190769","article-title":"Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen","volume":"25","author":"Gabibov","year":"2011","journal-title":"FASEB J"},{"key":"10.1074\/mcp.M115.056036_bib22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1542\/pir.33.4.164","article-title":"Guillain-Barre syndrome","volume":"33","author":"Rosen","year":"2012","journal-title":"Pediatrics Rev"},{"key":"10.1074\/mcp.M115.056036_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/CCLM.2001.052","article-title":"The intrathecal humoral immune response: laboratory analysis and clinical relevance","volume":"39","author":"Sindic","year":"2001","journal-title":"Clin. Chem. Lab. Med"},{"key":"10.1074\/mcp.M115.056036_bib24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/prca.200700081","article-title":"Proteomics of human cerebrospinal fluid - the good, the bad, and the ugly","volume":"1","author":"Zhang","year":"2007","journal-title":"Proteomics. Clin. Appl"},{"key":"10.1074\/mcp.M115.056036_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1468-1331.2007.01761.x","article-title":"Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients","volume":"14","author":"Jin","year":"2007","journal-title":"Eur.J. Neurol"},{"key":"10.1074\/mcp.M115.056036_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jneuroim.2007.01.022","article-title":"Proteome analysis of cerebrospinal fluid in Guillain-Barre syndrome (GBS)","volume":"185","author":"Lehmensiek","year":"2007","journal-title":"J. Neuroimmunol"},{"key":"10.1074\/mcp.M115.056036_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2010.08.060","article-title":"Protein profiling of Guillain-Barre syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry","volume":"485","author":"D'Aguanno","year":"2010","journal-title":"Neuroscience Lett"},{"key":"10.1074\/mcp.M115.056036_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10571-007-9257-7","article-title":"Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barre syndrome","volume":"28","author":"Yang","year":"2008","journal-title":"Cell. Mol. Neurobiol"},{"key":"10.1074\/mcp.M115.056036_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1074\/mcp.M115.056036_bib30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group","volume":"44","author":"Hadden","year":"1998","journal-title":"Anna. Neurol"},{"key":"10.1074\/mcp.M115.056036_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jnnp-2014-308220","article-title":"Electrodiagnosis of GBS subtypes by a single study: not yet the squaring of the circle","volume":"86","author":"Uncini","year":"2015","journal-title":"J. Neurol. Neurosurgery, Psychiatry"},{"key":"10.1074\/mcp.M115.056036_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Anna. Neurol"},{"key":"10.1074\/mcp.M115.056036_bib33","doi-asserted-by":"crossref","first-page":"D781","DOI":"10.1093\/nar\/gkj088","article-title":"IMGT\/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences","volume":"34","author":"Giudicelli","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.M115.056036_bib34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/pr070501k","article-title":"Integrated analysis of the cerebrospinal fluid peptidome and proteome","volume":"7","author":"Zougman","year":"2008","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M115.056036_bib35","doi-asserted-by":"crossref","first-page":"e42555","DOI":"10.1371\/journal.pone.0042555","article-title":"Peptidome analysis of cerebrospinal fluid by LC-MALDI MS","volume":"7","author":"Holtta","year":"2012","journal-title":"PloS One"},{"key":"10.1074\/mcp.M115.056036_bib36","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1007\/s00216-014-8058-3","article-title":"Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid","volume":"406","author":"Hyung","year":"2014","journal-title":"Anal. Bioanal. Chem"},{"key":"10.1074\/mcp.M115.056036_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizcaino","year":"2014","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M115.056036_bib38","doi-asserted-by":"crossref","first-page":"D1063","DOI":"10.1093\/nar\/gks1262","article-title":"The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013","volume":"41","author":"Vizcaino","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.M115.056036_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.molimm.2014.01.013","article-title":"Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation","volume":"62","author":"Lomakin","year":"2014","journal-title":"Mol. Immunol"},{"key":"10.1074\/mcp.M115.056036_bib40","doi-asserted-by":"crossref","first-page":"e101717","DOI":"10.1371\/journal.pone.0101717","article-title":"eulerAPE: drawing area-proportional 3-Venn diagrams using ellipses","volume":"9","author":"Micallef","year":"2014","journal-title":"PloS One"},{"key":"10.1074\/mcp.M115.056036_bib41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","article-title":"Guillain-Barre syndrome: an update","volume":"16","author":"Vucic","year":"2009","journal-title":"Clin. Neurosci"},{"key":"10.1074\/mcp.M115.056036_bib42","series-title":"Guillain-Barr\u00e9 syndrome","author":"Ropper","year":"1991"},{"key":"10.1074\/mcp.M115.056036_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2009.04.022","article-title":"Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barre syndrome and other neurological disorders","volume":"405","author":"Chiang","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1074\/mcp.M115.056036_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0404.2011.01511.x","article-title":"Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"125","author":"Zhang","year":"2012","journal-title":"Acta Neurol. Scandinavica"},{"key":"10.1074\/mcp.M115.056036_bib45","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00415-005-0817-9","article-title":"Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases","volume":"252","author":"Brettschneider","year":"2005","journal-title":"J. Neurol"},{"key":"10.1074\/mcp.M115.056036_bib46","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nn.2483","article-title":"Axonal prion protein is required for peripheral myelin maintenance","volume":"13","author":"Bremer","year":"2010","journal-title":"Nat. Neurosci"},{"key":"10.1074\/mcp.M115.056036_bib47","doi-asserted-by":"crossref","first-page":"19985","DOI":"10.1073\/pnas.1014074107","article-title":"Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)","volume":"107","author":"Mallery","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1074\/mcp.M115.056036_bib48","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1172\/JCI200415707","article-title":"The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome","volume":"114","author":"Godschalk","year":"2004","journal-title":"J. Clin. Investig"},{"key":"10.1074\/mcp.M115.056036_bib49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jneuroim.2006.11.006","article-title":"Primary cytomegalovirus infection in patients with Guillain-Barre syndrome","volume":"183","author":"Steininger","year":"2007","journal-title":"J. Neuroimmunol"},{"key":"10.1074\/mcp.M115.056036_bib50","first-page":"7","article-title":"Correlations between cytomegalovirus, Epstein-Barr virus, anti-ganglioside antibodies, electrodiagnostic findings and functional status in Guillain-Barre syndrome","volume":"13","author":"Taheraghdam","year":"2014","journal-title":"Iranian J. Neurol"},{"key":"10.1074\/mcp.M115.056036_bib51","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1529-8027.2007.00153.x","article-title":"Axonal Guillain-Barre syndrome: carbohydrate mimicry and pathophysiology","volume":"12","author":"Yuki","year":"2007","journal-title":"J. Peripheral Nervous Syst"},{"key":"10.1074\/mcp.M115.056036_bib52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1073\/pnas.0509849103","article-title":"Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen","volume":"103","author":"Ponomarenko","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1074\/mcp.M115.056036_bib53","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4049\/jimmunol.180.2.1258","article-title":"Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis","volume":"180","author":"Belogurov","year":"2008","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.M115.056036_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-510X(76)90083-6","article-title":"Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish peroxidase","volume":"29","author":"Jacobs","year":"1976","journal-title":"J. Neurol. Sci"},{"key":"10.1074\/mcp.M115.056036_bib55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ana.410090704","article-title":"Pathology of the Guillain-Barre syndrome","volume":"9","author":"Prineas","year":"1981","journal-title":"Anna. Neurol"},{"key":"10.1074\/mcp.M115.056036_bib56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2051-5960-2-5","article-title":"A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barre syndrome","volume":"2","author":"Yang","year":"2014","journal-title":"Acta Neuropathol. Commun"},{"key":"10.1074\/mcp.M115.056036_bib57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jprot.2015.05.010","article-title":"Is isolation of comprehensive human plasma peptidomes an achievable quest?","volume":"127","author":"Mahboob","year":"2015","journal-title":"J. Proteomics"},{"key":"10.1074\/mcp.M115.056036_bib58","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1086\/655136","article-title":"Increased risk of Guillain-Barre Syndrome following recent herpes zoster: a population-based study across Taiwan","volume":"51","author":"Kang","year":"2010","journal-title":"Clin. Infectious Dis"},{"key":"10.1074\/mcp.M115.056036_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF00684740","article-title":"Spread of herpes simplex virus in peripheral nerves","volume":"17","author":"Kristensson","year":"1971","journal-title":"Acta Neuropathol"},{"key":"10.1074\/mcp.M115.056036_bib60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bmj.1.5951.192","article-title":"Herpes simplex virus and Guillain-Barre polyradiculitis","volume":"1","author":"De Fine Olivarius","year":"1975","journal-title":"Br. Med. J"},{"key":"10.1074\/mcp.M115.056036_bib61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Anna. Neurol"},{"key":"10.1074\/mcp.M115.056036_bib62","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/brain\/awn281","article-title":"Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis","volume":"132","author":"Lonigro","year":"2009","journal-title":"Brain"},{"key":"10.1074\/mcp.M115.056036_bib63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barre syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J. Peripheral Nervous Syst"},{"key":"10.1074\/mcp.M115.056036_bib64","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology"},{"key":"10.1074\/mcp.M115.056036_bib65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0000000000000566","article-title":"Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barre syndrome","volume":"83","author":"Sawai","year":"2014","journal-title":"Neurology"},{"key":"10.1074\/mcp.M115.056036_bib66","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl. J. Med"},{"key":"10.1074\/mcp.M115.056036_bib67","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1212\/WNL.0b013e3182768b55","article-title":"Neurofascin antibodies in inflammatory neuropathy: how many needles make a haystack?","volume":"79","author":"Hughes","year":"2012","journal-title":"Neurology"},{"key":"10.1074\/mcp.M115.056036_bib68","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.autrev.2014.08.005","article-title":"Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies","volume":"13","author":"Lim","year":"2014","journal-title":"Autoimmunity Rev"},{"key":"10.1074\/mcp.M115.056036_bib69","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0000000000000581","article-title":"Ranvier revisited: novel nodal antigens stimulate interest in GBS pathogenesis","volume":"83","author":"Willison","year":"2014","journal-title":"Neurology"},{"key":"10.1074\/mcp.M115.056036_bib70","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.4049\/jimmunol.1301843","article-title":"TGF-beta: guardian of T cell function","volume":"191","author":"Oh","year":"2013","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.M115.056036_bib71","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1083\/jcb.129.2.443","article-title":"Transforming growth factor-beta 1 regulates axon\/Schwann cell interactions","volume":"129","author":"Einheber","year":"1995","journal-title":"J. Cell Biol"},{"key":"10.1074\/mcp.M115.056036_bib72","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1083\/jcb.110.4.1361","article-title":"Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin","volume":"110","author":"Lyons","year":"1990","journal-title":"J. Cell Biol"},{"key":"10.1074\/mcp.M115.056036_bib73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1189\/jlb.0708415","article-title":"Review of the activation of TGF-beta in immunity","volume":"85","author":"Taylor","year":"2009","journal-title":"J. Leukocyte Biol"},{"key":"10.1074\/mcp.M115.056036_bib74","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1600-0463.2003.apm1111204.x","article-title":"Elevated number of cells secreting transforming growth factor beta in Guillain-Barre syndrome","volume":"111","author":"Dahle","year":"2003","journal-title":"APMIS"},{"key":"10.1074\/mcp.M115.056036_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1468-1331.2000.00005.x","article-title":"Expression of TNFalpha and TGFbeta1 in Guillain-Barre syndrome: correlation of a low TNFalpha-\/TGFbeta1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment","volume":"7","author":"Ossege","year":"2000","journal-title":"Eur. J. Neurol"},{"key":"10.1074\/mcp.M115.056036_bib76","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/brain\/awg030","article-title":"Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies","volume":"126","author":"Kwa","year":"2003","journal-title":"Brain"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620335222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620335222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M115.056036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:49:37Z","timestamp":1761526177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620335222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1535947620335222"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m115.056036","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M115.056036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}